基于TGFβ1-miRNA224探讨补肾促排卵汤治疗体外受精-胚胎移植助孕的多囊卵巢综合征肾虚证临床研究OA
Clinical efficacy of Bushen Cupailuan decoction in kidney-deficiency PCOS patients undergoing IVF-ET:Evidence from the TGF-β1-miR-224 pathway
目的:观察补肾促排卵汤对体外受精-胚胎移植(IVF-ET)助孕的肾虚证多囊卵巢综合征(PCOS)患者的临床疗效以及卵泡液micro-RNA224(miR-224)和转化生长因子-β1(TGF-β1)表达的影响.方法:入组30例行长方案IVF助孕的单纯输卵管因素不孕症患者为空白组;另外入组60例行长方案IVF助孕的肾虚证PCOS患者,其中治疗组和对照组各30例,治疗组使用补肾促排卵汤联合生活指导3个周期后进入IVF周期,对照组单纯生活指导3个周期后进入IVF周期.观察三组干预前后血清睾酮(T)、促黄体生成素(LH)、抗苗勒管激素(AMH)、体重指数(BMI)、中医证候评分的变化.观察IVF周期结束后三组的使用促性腺激素(GN)天数、使用GN总量、双原核受精率(2PN率)、2PN卵裂率、优质胚胎率、冻胚移植(FET)周期临床妊娠率以及早期流产率.观察三组卵泡液中miR-224、TGF-β1、雌二醇(E2)和孕酮(P)的分泌.结果:治疗组经过治疗后,血清中T、LH、AMH较治疗前明显下降,中医证候评分较治疗前明显下降,差异均有统计学意义(P<0.05).而对照组在经过生活指导干预后性激素、BMI、中医证候评分与干预前比较,差异均无统计学意义(P>0.05).治疗组与对照组干预后临床结局比较,GN总量及GN天数差异均无统计学意义(P>0.05);治疗组2PN率、2PN卵裂率、优胚率高于对照组,差异均有统计学意义(P<0.05);治疗组卵泡液中E2分泌高于对照组,miR-224、TGF-β1、P分泌低于对照组,差异均有统计学意义(P<0.05).治疗组FET临床妊娠率高于对照组,差异有统计学意义(P<0.05);治疗组FET早期流产低于对照组,但差异无统计学意义(P>0.05).结论:补肾促排卵汤可有效改善PCOS患者基础内分泌激素分泌;可调控卵泡液miR-224、TGFβ1的表达,降低排卵前miR-224的表达实现TGF-β1对颗粒细胞增殖和类固醇激素分泌的调控,这可能是改善卵子质量,提高优胚率,提高临床妊娠率的原因.
Objective:To investigate the clinical efficacy of Bushen Cupailuan decoction in patients with polycys-tic ovary syndrome(PCOS)characterized by kidney deficiency syndrome undergoing in vitro fertilization-embryo transfer(IVF-ET),and to examine its effects on the expression of microRNA-224(miR-224)and transforming growth factor-β1(TGF-β1)in follicular fluid.Methods:Thirty patients with infertility due to isolated tubal factors undergoing IVF with a long protocol were enrolled as the blank group.In addition,60 PCOS patients with kidney de-ficiency syndrome undergoing IVF with the same long protocol were recruited and randomly assigned to a treatment group(n=30)and a control group(n=30).The treatment group received Bushen Cupailuan decoction combined with lifestyle guidance for three cycles before entering the IVF cycle,whereas the control group received lifestyle guidance alone for three cycles before IVF.Changes in serum testosterone(T),luteinizing hormone(LH),anti-Müllerian hormone(AMH),body mass index(BMI),and traditional Chinese medicine(TCM)syndrome scores were assessed before and after intervention.After completion of the IVF cycle,the number of gonadotropin(GN)days,total GN dosage,two-pronuclear fertilization rate(2PN rate),2PN cleavage rate,high-quality embryo rate,clin-ical pregnancy rate in frozen embryo transfer(FET)cycles,and early miscarriage rate were compared among the three groups.Levels of miR-224,TGF-β1,estradiol,and progesterone in follicular fluid were also measured.Results:After treatment,the treatment group showed significant decreases in serum T,LH,and AMH levels,as well as TCM syndrome scores,compared with baseline(all P<0.05).In contrast,the control group showed no significant changes in sex hormone levels,BMI,or TCM syndrome scores after lifestyle intervention(P>0.05).When clinical outcomes were compared between the treatment and control groups after intervention,no significant differences were found in total GN dosage or duration of GN use(all P>0.05).However,the treatment group had significantly higher 2PN rate,2PN cleavage rate,and high-quality embryo rate than the control group(all P<0.05).In follicular fluid,estradi-ol secretion was significantly higher in the treatment group,while miR-224,TGF-β1,and progesterone levels were significantly lower than those in the control group(all P<0.05).The clinical pregnancy rate in FET cycles was sig-nificantly higher in the treatment group than in the control group(P<0.05).The early miscarriage rate in FET cy-cles was lower in the treatment group,although the difference was not statistically significant(P>0.05).Conclusion:Bushen Cupailuan decoction effectively improves baseline endocrine hormone secretion in PCOS patients.It may regu-late the expression of miR-224 and TGF-β1 in follicular fluid.By reducing pre-ovulatory miR-224 expression,the de-coction may enable TGF-β1-mediated regulation of granulosa cell proliferation and steroid hormone secretion,thereby improving oocyte quality,increasing the proportion of high-quality embryos,and ultimately enhancing clinical preg-nancy rates.
童星丽;郭银华
南京中医药大学附属医院,江苏南京 210029南京中医药大学附属医院,江苏南京 210029
医药卫生
多囊卵巢综合征肾虚证补肾促排卵汤卵泡液miR-224转化生长因子-β1
Polycystic ovary syndromeKidney deficiency syndromeBushen Cupailuan decoctionFollicular fluidmiR-224Transforming growth factor-β1
《陕西中医》 2026 (9)
1195-1201,7
国家重点研发计划项目(2024YFC3505804)江苏省中医药管理局科技项目(K201818)江苏省中医药科技发展计划面上项目(MS2024019)
评论